DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (2)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Brainlab to become distributor of Elekta's stereotactic neurosurgery products in US Already the supplier in select European markets

Q&A with David Pacitti, President of Siemens Medical Solutions USA, Inc. and Head of Siemens Healthineers North America Insights from the show floor at RSNA

Hitachi acquires Mitsubishi Electric’s particle therapy system business Will integrate with Hitachi's own particle therapy division to form one entity

3-D printed middle-ear to correct hearing loss shows promise at RSNA Further evidence of CT and 3-D printing synergy

Edwards acquires Harpoon Medical Company now owns the image-guiding HARPOON System

Philips acquires VitalHealth for an undisclosed amount Adds to its population health management portfolio

Dignity Health, Catholic Health Initiatives agree to merge into giant, new Catholic health system Will provide care in 28 states

Image Diagnostics monitor to be enhanced with new video management system Add-on to the first large field 4k mobile and multi-modality monitor

Frans van Houten, CEO of Philips, on the future of radiology Discussing the demands for relevant innovations and the arrival of 'clinical data scientists'

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

Frans van Houten at RSNA

Discussing RSNA with Philips CEO, Frans van Houten

by Gus Iversen , Editor in Chief
In an exclusive interview, Frans van Houten, CEO of Royal Philips, spoke to HCB News about a wide range of topics pertaining to RSNA and the future of medical imaging.

From the evolving role of radiologists to a comparison between software innovation and hardware innovation, to the political situation in the U.S. and its global implications for value-based care. Here, lightly modified for cohesiveness and clarity, is our conversation:

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



HCB News: For Philips, in what ways was this year's RSNA different from previous years?

Frans van Houten: For us, RSNA this year was very much focused on clinical informatics that bring the health continuum together.

We introduced solutions for more integrated care pathways supported by clinical analytics, and showed how artificial intelligence applications can make radiologists much more productive. For example, to do longitudinal cancer tumor assessment over multiple modalities — whether PET, CT, X-ray, MR or ultrasound, from any vendor — we can go through the longitudinal records of a patient and automatically quantify how the tumor is evolving.

It was an RSNA where we showed that data can be made actionable. In the past, RSNA has been about image acquisition through scanners. We still do that but besides great acquisition devices, we’ve demonstrated we can also generate data specific to a patient and make the doctor more productive, and free-up time to be more patient-centric.

The reaction from radiologists can vary. Some fear that machines will take over their tasks while others can see that these innovations are helping to determine the best way to treat the patient. Obviously we believe the latter — and that this will be the norm in the future.

HCB News: What do you tell those radiologists who are worried about becoming obsolete?

FVH: I think that fear is wrong. Clinical informatics can take over routine tasks and quantification, and free up time so radiologists can be more productive and see more patients. The picture we paint is one where there will be an emerging role for a chief clinical data scientist.

Who is bringing together the data from these various fields? You need custodianship and stewardship over all that data and then to interpret it, in order to come to a definitive diagnosis.

What is statistically the treatment pathway that has the best possible outcome? I think that is where doctors will spend more time in the future, rather then in the dark room manually measuring how many millimeters the tumor has evolved.
  Pages: 1 - 2 - 3 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED